Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 19 January 2026 to 5 January 2030
Manufacture and testing of over-encapsulated tablets and matching placebo capsules specifically for the LAMDARCT clinical trial. The work involves pharmaceutical production and quality control testing to meet research standards for clinical trial supply.
- Awarded value
- £494k
- As published
- Published
- 8 December 2025
- Contract length
- 48 months
- Ends 5 January 2030